Stoma/Ostomy Care Market Report 2023: R&D Consistency Drives Sector Growth

The global stoma/ostomy care market is projected to reach a value of US$ 3.8 billion by the end of 2022, and is expected to grow at a compound annual growth rate (CAGR) of 4.9% during the forecast period from 2023 to 2033, reaching a market value of approximately US$ 6.5 billion by 2033. The growth of the stoma care market is attributed to factors such as the increasing prevalence of diseases requiring ostomy care, advancements in surgical techniques and ostomy products, greater awareness, and reimbursements.

The most common diseases requiring ostomy care are colorectal cancer, bladder cancer, and inflammatory bowel disease, which are treated with surgical excision of aggressive melanoma of the intestine (IBD). In some cases, an ostomy is required, which involves making a surgical incision through the abdomen to create a new waste minimization conduit.

The adoption of stoma/ostomy care procedures has increased worldwide due to the rising occurrence of these diseases and increased exposure to risk factors such as changing eating habits and increased antibiotic use in children.

However, despite recent advancements, the stoma/ostomy market faces several constraints that limit its growth potential. These include stoma care issues, discomfort and other concerns associated with ostomy products, societal stigma, and increased acceptance of alternative therapies, particularly in developing countries.

While stoma surgeries are generally safe, there are some risks involved, including life-threatening issues such as necrosis and exhaustion. As a result, the acceptance of stoma care appliances may be limited to some extent.

Key players in the Stoma/Ostomy Care Market

BAE Systems Plc, ConvaTec Inc., Hollister Inc., EuroMed, Inc, 3M Company, Smith & Nephew plc, FNC Medical, Nu–Hope Laboratories, Inc., Marlen Manufacturing & Development Co., Torbot Group, Inc, Cymed Micro Skin, Alcare Co., Ltd., B. Braun Melsungen AG., Salts Healthcare Ltd, Securi–T USA., Welland Medical Limited, Flexicare Group Limited.

Get More Details@ https://www.futuremarketinsights.com/reports/stoma-ostomy-care-market

Key Segments

By Surgery Type:

  • Colostomy
  • Ileostomy
  • Urostomy

By Product:

  • Ostomy Bags
  • Ostomy Accessories
    • Belts & Tapes
    • Skin Protection &Skin Barrier
    • Irrigation Sets
    • Convex Inserts
    • Stoma Caps

By Application:

  • Cancer
  • Inflammatory Bowel Disease
  • Bowel Obstruction
  • Fecal Incontinence
  • Trauma and Infection

By End–Users:

  • Hospitals and Specialty Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more